Hogaboam, Cory M.

The link between fungi and severe asthma: A summary of the evidence

Denning, D. W., O'Driscoll, B. R., Hogaboam, C. M., Bowyer, P., & Niven, R. M. (2006) · European Respiratory Journal

Asthma and respiratory diseasesAntifungal resistance and susceptibility

Cited by 824

TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P

Murray, L. A., Chen, Q., Kramer, M. S., Hesson, D. P., Argentieri, R. L., Peng, X., Gulati, M., Homer, R. J., Russell, T., van Rooijen, N., et al. (2011) · The International Journal of Biochemistry & Cell Biology

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisTGF-β signaling in diseases

Cited by 362

Epigenetic Changes in Bone Marrow Progenitor Cells Influence the Inflammatory Phenotype and Alter Wound Healing in Type 2 Diabetes

Gallagher, K. A., Joshi, A., Carson, W. F., Schaller, M., Allen, R., Mukerjee, S., Kittan, N., Feldman, E. L., Henke, P. K., Hogaboam, C., et al. (2015) · Diabetes

Wound Healing and TreatmentsEpigenetics and DNA Methylation

Cited by 206

Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo

Hohmann, M. S., Habiel, D. M., Coelho, A. L., Verri, W. A., & Hogaboam, C. M. (2019) · American Journal of Respiratory Cell and Molecular Biology

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisTelomeres, Telomerase, and Senescence

Cited by 202

Prostaglandin E 2 induces fibroblast apoptosis by modulating multiple survival pathways

Huang, S. K., White, E. S., Wettlaufer, S. H., Grifka, H., Hogaboam, C. M., Thannickal, V. J., Horowitz, J. C., & Peters-Golden, M. (2009) · The FASEB Journal

Inflammatory mediators and NSAID effectsInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 147

Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis

Huang, Y., Ma, S.-F., Espindola, M. S., Vij, R., Oldham, J. M., Huffnagle, G. B., Erb-Downward, J. R., Flaherty, K. R., Moore, B. B., White, E. S., et al. (2017) · American Journal of Respiratory and Critical Care Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseases

Cited by 142

Macrophages in allergic asthma: fine-tuning their pro- and anti-inflammatory actions for disease resolution

Moreira, A. P., & Hogaboam, C. M. (2011) · Journal of Interferon & Cytokine Research

Asthma and respiratory diseasesImmune cells in cancer

Cited by 139

STAT3-Mediated Signaling Dysregulates Lung Fibroblast-Myofibroblast Activation and Differentiation in UIP/IPF

Pechkovsky, D. V., Prêle, C. M., Wong, J., Hogaboam, C. M., McAnulty, R. J., Laurent, G. J., Zhang, S. S.-M., Selman, M., Mutsaers, S. E., & Knight, D. A. (2012) · The American Journal of Pathology

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and Treatments

Cited by 127

Categorization of lung mesenchymal cells in development and fibrosis

Liu, X., Rowan, S. C., Liang, J., Yao, C., Huang, G., Deng, N., Xie, T., Wu, D., Wang, Y., Burman, A., et al. (2021) · iScience

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSingle-cell and spatial transcriptomics

Cited by 91

Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy

Ren, X., Hogaboam, C., Carpenter, A., & Colletti, L. (2003) · Journal of Clinical Investigation

Liver physiology and pathologyCytokine Signaling Pathways and Interactions

Cited by 80

Measurement of MMP‐9 and ‐12 degraded elastin (ELM) provides unique information on lung tissue degradation

Skjøt-Arkil, H., Clausen, R. E., Nguyen, Q. H. T., Wang, Y., Zheng, Q., Martinez, F. J., Hogaboam, C. M., Han, M., Klickstein, L. B., Larsen, M. R., et al. (2012) · BMC Pulmonary Medicine

Protease and Inhibitor MechanismsInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 65

Mitogenic Properties of Endogenous and Pharmacological Doses of Macrophage Inflammatory Protein-2 after 70% Hepatectomy in the Mouse

Ren, X., Carpenter, A., Hogaboam, C., & Colletti, L. (2003) · The American Journal of Pathology

Liver physiology and pathologyWound Healing and Treatments

Cited by 64

LTI-03 peptide demonstrates anti-fibrotic activity in ex vivo lung slices from patients with IPF

MacKenzie, B., Mahavadi, P., Pinho Jannini-Sa, Y. A., Creyns, B., Coelho, A. L., Espindola, M., Ruppert, C., Windsor, B., Aigner, C., Hogaboam, C. M., et al. (2025) · iScience

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisSystemic Sclerosis and Related Diseases

Cited by 2

Evaluating Alveolar Regenerative Properties of Caveolin Scaffolding Peptides (CSD) in Three Dimensional (3D) Alveolospheres From IPF and Normal Donor Lung Samples

Sa, Y. A. P. J. D., Coelho, A. L., Mackenzie, B., & Hogaboam, C. M. (2025) · American Journal of Respiratory and Critical Care Medicine

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisNeonatal Respiratory Health Research

Cited by 1

Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation study

Molyneaux, P. L., Hirani, N. A., Chia, C. C. K., Kulkarni, T., Zaman, T., Kaner, R. J., Coelho, A. L., Jannini-Sa, Y. A. P., Windsor, B., Kruger, S., et al. (2026) · Nature Communications

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseases

Cited by 1

Caveolin Scaffolding Domain LTI-03 Modulates Both Inflammatory and Fibrotic Responses in Aged Mice After Bleomycin Challenge

Mackenzie, B., Maier, E., Creyns, B., Coelho, A. L., Windsor, B., & Hogaboam, C. M. (2022) · A107. MECHANISMS OF FIBROSIS/FIBROBLAST BIOLOGY

Caveolin-1 and cellular processesInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Cited by 0